Targeting Myeloid-Derived Suppressor Cells in Advanced Cancer

(MedPage Today) -- Targeting myeloid-derived suppressor cells (MDSCs) has become a promising area of cancer research, with a goal toward improving the efficacy of immunotherapies. At the recent virtual American Society of Clinical Oncology (ASCO...